Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor-Reference-Cited by-同舟云学术

Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor

Published:2022-08-05 Issue:6 Volume:35 Page:2002-2010
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Akiyama Taro,Yoshimatsu Yuki,Noguchi Rei,Sin Yooksil,Tsuchiya Ryuto,Ono Takuya,Sato Chiaki,Kojima Naoki,Yoshida Akihiko,Kawai Akira,Ohtori Seji,Kondo Tadashi^ORCID

Funder

the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

https://link.springer.com/content/pdf/10.1007/s13577-022-00751-z.pdf

Reference36 articles.

1. Brennan B, Stiller C, Bourdeaut F. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol. 2013;14:e329–36.

2. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7–15.

3. Kohashi K, Yamada Y, Hotokebuchi Y, et al. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol. 2015;46:225–30.

4. Kohashi K, Tanaka Y, Kishimoto H, et al. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features. Mod Pathol. 2016;29:1232–42.

5. Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer. 2007;110:2061–6.